Kestra Advisory Services, LLC Catalent, Inc. Transaction History

Kestra Advisory Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$87.2 - $114.05 $152,861 - $199,929	1,753 Added 87.78%	3,750 $402,000
Q1 2022 Apr 26, 2022	SELL	$94.19 - $124.49 $12,433 - $16,432	-132 Reduced 6.2%	1,997 $221,000
Q4 2021 Jan 20, 2022	BUY	$119.57 - $139.07 $14,946 - $17,383	125 Added 6.24%	2,129 $272,000
Q3 2021 Oct 19, 2021	BUY	$109.17 - $142.35 $218,776 - $285,269	2,004 New	2,004 $266,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.